SUPN Annual Non Current Assets
$784.56 M
-$183.80 M-18.98%
31 December 2023
Summary:
As of January 21, 2025, SUPN annual long term assets is $784.56 million, with the most recent change of -$183.80 million (-18.98%) on December 31, 2023. During the last 3 years, it has fallen by -$89.13 million (-10.20%). SUPN annual non current assets is now -27.86% below its all-time high of $1.09 billion, reached on December 31, 2021.SUPN Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SUPN Quarterly Non Current Assets
$702.70 M
-$22.13 M-3.05%
30 September 2024
Summary:
As of January 21, 2025, SUPN quarterly long term assets is $702.70 million, with the most recent change of -$22.13 million (-3.05%) on September 30, 2024. Over the past year, it has dropped by -$133.10 million (-15.93%). SUPN quarterly non current assets is now -35.39% below its all-time high of $1.09 billion, reached on December 31, 2021.SUPN Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SUPN Non Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -19.0% | -15.9% |
| 3 y3 years | -10.2% | -15.9% |
| 5 y5 years | +62.0% | -15.9% |
SUPN Non Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -27.9% | at low | -35.4% | at low |
| 5 y | 5-year | -27.9% | +14.1% | -35.4% | +11.0% |
| alltime | all time | -27.9% | >+9999.0% | -35.4% | >+9999.0% |
Supernus Pharmaceuticals Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $702.70 M(-3.1%) |
| June 2024 | - | $724.83 M(-4.6%) |
| Mar 2024 | - | $759.77 M(-3.2%) |
| Dec 2023 | $493.11 M(-32.8%) | $784.56 M(-6.1%) |
| Sept 2023 | - | $835.80 M(-3.9%) |
| June 2023 | - | $869.56 M(-4.3%) |
| Mar 2023 | - | $908.47 M(-6.2%) |
| Dec 2022 | $734.15 M(+22.0%) | $968.36 M(-5.9%) |
| Sept 2022 | - | $1.03 B(-3.8%) |
| June 2022 | - | $1.07 B(-0.1%) |
| Mar 2022 | - | $1.07 B(-1.5%) |
| Dec 2021 | $601.59 M(-4.6%) | $1.09 B(+22.7%) |
| Sept 2021 | - | $886.66 M(-5.0%) |
| June 2021 | - | $933.82 M(+1.3%) |
| Mar 2021 | - | $921.42 M(+5.5%) |
| Dec 2020 | $630.42 M(+33.4%) | $873.68 M(-8.8%) |
| Sept 2020 | - | $958.01 M(+2.6%) |
| June 2020 | - | $933.87 M(+47.6%) |
| Mar 2020 | - | $632.82 M(-8.0%) |
| Dec 2019 | $472.64 M(-4.2%) | $687.64 M(+1.1%) |
| Sept 2019 | - | $679.83 M(+1.0%) |
| June 2019 | - | $672.76 M(+11.1%) |
| Mar 2019 | - | $605.48 M(+25.0%) |
| Dec 2018 | $493.49 M(+116.0%) | $484.32 M(-9.0%) |
| Sept 2018 | - | $531.96 M(-6.4%) |
| June 2018 | - | $568.28 M(+134.9%) |
| Mar 2018 | - | $241.91 M(+23.4%) |
| Dec 2017 | $228.45 M | $196.01 M(+1.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2017 | - | $194.15 M(+7.3%) |
| June 2017 | - | $180.88 M(+4.9%) |
| Mar 2017 | - | $172.50 M(+9.1%) |
| Dec 2016 | $151.40 M(+42.9%) | $158.16 M(+7.7%) |
| Sept 2016 | - | $146.91 M(+40.6%) |
| June 2016 | - | $104.49 M(+4.0%) |
| Mar 2016 | - | $100.52 M(+21.6%) |
| Dec 2015 | $105.95 M(-2.6%) | $82.68 M(+28.7%) |
| Sept 2015 | - | $64.22 M(+32.6%) |
| June 2015 | - | $48.43 M(+27.0%) |
| Mar 2015 | - | $38.13 M(+35.9%) |
| Dec 2014 | $108.73 M(+11.9%) | $28.06 M(+20.1%) |
| Sept 2014 | - | $23.36 M(+5.2%) |
| June 2014 | - | $22.21 M(+26.3%) |
| Mar 2014 | - | $17.59 M(+27.2%) |
| Dec 2013 | $97.16 M(+6.2%) | $13.83 M(-33.8%) |
| Sept 2013 | - | $20.90 M(-2.1%) |
| June 2013 | - | $21.36 M(+682.6%) |
| Mar 2013 | - | $2.73 M(+8.0%) |
| Dec 2012 | $91.46 M(+85.1%) | $2.53 M(-38.7%) |
| Sept 2012 | - | $4.13 M(+91.0%) |
| June 2012 | - | $2.16 M(-54.9%) |
| Mar 2012 | - | $4.79 M(+10.5%) |
| Dec 2011 | $49.40 M(+24.1%) | $4.33 M(-41.4%) |
| Sept 2011 | - | $7.39 M(+2.7%) |
| Dec 2010 | $39.81 M(-45.4%) | $7.20 M(+14.9%) |
| Sept 2010 | - | $6.26 M(-10.8%) |
| Dec 2009 | $72.88 M(+4.9%) | $7.02 M |
| Dec 2008 | $69.46 M | - |
FAQ
- What is Supernus Pharmaceuticals annual long term assets?
- What is the all time high annual non current assets for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals annual non current assets year-on-year change?
- What is Supernus Pharmaceuticals quarterly long term assets?
- What is the all time high quarterly non current assets for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals quarterly non current assets year-on-year change?
What is Supernus Pharmaceuticals annual long term assets?
The current annual non current assets of SUPN is $784.56 M
What is the all time high annual non current assets for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high annual long term assets is $1.09 B
What is Supernus Pharmaceuticals annual non current assets year-on-year change?
Over the past year, SUPN annual long term assets has changed by -$183.80 M (-18.98%)
What is Supernus Pharmaceuticals quarterly long term assets?
The current quarterly non current assets of SUPN is $702.70 M
What is the all time high quarterly non current assets for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high quarterly long term assets is $1.09 B
What is Supernus Pharmaceuticals quarterly non current assets year-on-year change?
Over the past year, SUPN quarterly long term assets has changed by -$133.10 M (-15.93%)